MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2017.03.601

Медицинская библиотека · Journal of the American College of Cardiology · 2017

Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.

Lønborg Jacob, Engstrøm Thomas, Ahtarovski Kiril Aleksov, Nepper-Christensen Lars, Helqvist Steffen, Vejlstrup Niels, Kyhl Kasper, Schoos Mikkel Malby, Ghotbi Ali, Göransson Christoffer, Bertelsen Litten, Holmvang Lene, Pedersen Frants, Jørgensen Erik, Saunamäki Kari, Clemmensen Peter, De Backer Ole, Kløvgaard Lene, Høfsten Dan Eik, Køber Lars, Kelbæk Henning, DANAMI-3 Investigators

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Although some studies found improved coronary flow and myocardial salvage when stent implantation was deferred, the DANAMI-3-DEFER (Third DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction) did not show any improvement in clinical outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) and deferred stenting.

OBJECTIVES

This study sought to evaluate the effect of deferred stent implantation on infarct size, myocardial salvage, and microvascular obstruction (MVO) in patients with STEMI.

METHODS

In the present DANAMI-3 substudy, a total of 510 patients with STEMI were randomized to PCI with deferred versus immediate stent implantation. The patients underwent a cardiac magnetic resonance examination before discharge after the index procedure and again 3 months later. The primary endpoint was final infarct size.

RESULTS

Deferred stenting did not reduce final infarct size (9% left ventricle [LV]; interquartile range [IQR]: 3% to 18% vs. 10% LV; IQR: 3% to 18%; p = 0.67). Similarly, deferred stenting was not associated with myocardial salvage index (66%; IQR: 50% to 89% vs. 67%; IQR: 49% to 88%; p = 0.80) or presence of MVO (43% vs. 42%; p = 0.78). In a post hoc analysis, stent length was the only subgroup of 7 that had an effect on outcome. In patients with a stent length ≥24 mm, deferred stenting reduced the final infarct size (6% LV; IQR: 2% to 18% vs. 13% LV; IQR: 7% to 23%; p = 0.006; and p for interaction = 0.005).

CONCLUSIONS

In the DANAMI-3-DEFER cardiac magnetic resonance substudy, routine deferred stenting did not reduce infarct size or MVO and did not increase myocardial salvage. These results do not support the use of routine deferred stenting in STEMI patients treated with primary PCI. (DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction [DANAMI-3]; NCT01435408).

Для цитирования: Lønborg Jacob, Engstrøm Thomas, Ahtarovski Kiril Aleksov, Nepper-Christensen Lars, Helqvist Steffen, Vejlstrup Niels, Kyhl Kasper, Schoos Mikkel Malby, Ghotbi Ali, Göransson Christoffer, Bertelsen Litten, Holmvang Lene, Pedersen Frants, Jørgensen Erik, Saunamäki Kari, Clemmensen Peter, De Backer Ole, Kløvgaard Lene, Høfsten Dan Eik, Køber Lars, Kelbæk Henning, DANAMI-3 Investigators. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.. Journal of the American College of Cardiology. 2017. DOI: 10.1016/j.jacc.2017.03.601.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.